Share on StockTwits

Muscle Pharm Co.. (NASDAQ:MSLP) CEO Brad J. Pyatt purchased 2,500 shares of the company’s stock in a transaction that occurred on Thursday, August 14th. The stock was purchased at an average cost of $11.48 per share, with a total value of $28,700.00. Following the transaction, the chief executive officer now directly owns 558,222 shares of the company’s stock, valued at approximately $6,408,389. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Muscle Pharm Co.. (NASDAQ:MSLP) traded up 2.73% on Friday, hitting $11.30. The stock had a trading volume of 26,478 shares. Muscle Pharm Co.. has a 52 week low of $6.16 and a 52 week high of $12.40. The stock has a 50-day moving average of $11.5 and a 200-day moving average of $9.. The company’s market cap is $125.7 million.

Muscle Pharm Co.. (NASDAQ:MSLP) last announced its earnings results on Monday, August 4th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.11. On average, analysts predict that Muscle Pharm Co.. will post $0.20 earnings per share for the current fiscal year.

MusclePharm Corporation (NASDAQ:MSLP) is engaged in the business of providing personal fitness training using isometric techniques (Tone in Twenty).

Receive News & Ratings for Muscle Pharm Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Muscle Pharm Co and related companies with Analyst Ratings Network's FREE daily email newsletter.